GRI Bio increases ATM offering capacity by up to $1.67M, on top of $3.6M already sold

GRI Bio, Inc.

Prospectus supplement filed to increase ATM issuance by up to $1.67M, on top of $3.6M previously sold.
Shares sold to date total $3,604,683; new maximum of $1,670,956 does not include prior sales.
ATM sales agreement with H.C. Wainwright dated May 20, 2024; offering of common stock provides incremental equity financing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.